83-2270-65 [受注停止]KRIBIOLISA Daratumumab (DARZALEX) ELISA 1 x 96 wells KBI1028

[KRISHGEN BioSystems]

※お見積書はカートで印刷できます

劇物 冷蔵

特徴

  • Description:Enzyme Immunoassay for the quantitative determination of Daratumumab in serum, plasma and cell culture supernatant.
  • Daratumumab (trade name Darzalex) is an anti-cancer drug.
  • It binds to CD38, which multiple myeloma cells overexpress.
  • Daratumumab was originally developed by Genmab, but it is now being jointly developed by Genmab along with the Johnson & Johnson subsidiary Janssen Biotech, which acquired worldwide commercialization rights to the drug from Genmab.Daratumumab was given breakthrough therapy drug status in 2013 for multiple myeloma.
  • It was awarded orphan drug status for multiple myeloma, diffuse large B cell
  • lymphoma, follicular lymphoma, and mantle cell lymphoma.
  • Krishgen PK kits, developed using the innovator drug as calibrator, are used for the quantitation of serum protein drug levels, and can be used for biosimilar and generics research as well.
  • About the kit:
  • - Uses anti-idiotypic antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity.
  • - Recovery rates are between 85 - 115%
  • - Ready to use with a standard protocol with break-apart pre-coated wells
  • - Validated as per US FDA guidelines for Bioassays
  • - Optimized for matrix effects to ensure higher sensitivity.
  • - Shelf life: 1 year
  • The method employs the quantitative sandwich enzyme immunoassay technique.
  • Antibodies to Daratumumab are pre-coated onto microwells.
  • Samples and standards are pipetted into microwells and human Daratumumab present in the sample are bound by the capture antibody.
  • Then, a HRP (horseradish peroxidase) conjugated anti-Daratumumab antibody is pipetted and incubated.
  • After washing microwells in order to remove any non-specific binding, the ready to use substrate solution (TMB) is added to microwells
  • and color develops proportionally to the amount of Daratumumab in the sample.
  • Color development is then stopped by addition of stop solution.
  • Absorbance is measured at 450 nm.

仕様

  • サイズ:1 x 96 wells
  • Reactivity:Human, Mouse and Rat Available for Customisation
  • アプリケーション:ELISA,Immunoassay
  • Sensitivity:0.2 ug/ml
  • Calibration Range:0 - 100 ug/ml
  • サンプルタイプ:Serum, Plasma, and Cell Culture Supernatant
  • データシート:https://krishgen.com/upload/datasheets/KBI1028-Daratumumab-IFU-ver1.0-CE-mlang.pdf
  • 測定方法:Colorimetric, 450nm
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
83-2270-65
型番
KBI1028
入り数
1個
標準価格
353,000円(税抜)
WEB価格
受注停止
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る